How To Invest In Replimune Group, Inc. Stock - REPL Share Price Today & News | Stash
Invest in Replimune Group, Inc. on Stash
Replimune Group, Inc. is a clinical-stage biotechnology company.
To buy fractional shares of Replimune Group, Inc. stock, you'll need to sign up for Stash and open a personal portfolio. Stash allows you to purchase smaller pieces of investments, called fractional shares, rather than having to pay the full price for a whole share.
Replimune Group, Inc. Stock Information
- Ticker: REPL
- Current Price: $10.23
- Change: -7.92% (1W)
Replimune Group, Inc. Performance Breakdown
- Today's change: 7.46%
- Year to date change (YTD): 14.94%
- Dividend yield: 0.0
- Last dividend paid: N/A
- Last dividend pay date: N/A
About REPL
Replimune Group, Inc. is engaged in the field of oncolytic immunotherapy to treat cancer patients. The Company applies its Immulytic platform to design and develop product candidates intended to maximally activate the immune system against solid tumors. It focuses on developing a pipeline of oncolytic immunotherapy product candidates to provide clinical benefits to cancer patients. Its product candidates include RP, RP2, and RP3. The Company is engaged in a Phase 1/2 clinical trial with its lead product candidate, RP1, in approximately 150 patients with a range of solid tumors.
How to Buy Replimune Group, Inc. Stock on Stash
- Enter the amount you'd like to invest in Replimune Group, Inc. stock, then proceed to checkout. Stash allows you to purchase smaller, more affordable pieces of investments (called fractional shares) rather than the whole share, which can be significantly more expensive.
- Set up your investment account in just a few minutes. The Stash Plan can help you reach different goals and offers a unique combination of financial accounts and features.
- Once your market order of Replimune Group, Inc. stock is complete, you'll officially be a shareholder of Replimune Group, Inc.!
Historical Performance Data Disclaimer
The historical performance data for individual securities quoted on this website represents past performance reported as an average annual return for a given time horizon. Historical performance data is provided "as is" and solely for informational purposes, is not advice, and should not be relied upon as the sole basis for making any investment decision.